Discontinued
RETEVMO selpercatinib 40 mg immediate release capsules
selpercatinib · 40 mg Capsule, hard
- Deletion from market
- 31 Oct 2026
- TGA row last updated
- 11 June 2026
- ARTG ID
- 391331
- Sponsor
- Eli Lilly Australia Pty Ltd
- Sponsor phone
- 0459667315
- Shortage impact
- Low
- Availability
- Reduction in supply until supply is exhausted
Reason reported to TGA
Commercial Changes / Commercial viability
TGA management action
This product will be replaced by RETEVMO selpercatinib 40 mg film-coated tablets blister pack (466116)
What to do
- 1.This product is discontinued in the TGA export — Ask your prescriber or pharmacist about a product that is still supplied. Do not stop treatment without that advice.
Official sources
Last updated from the TGA Medicine Shortage Reports Database (report generated 12 November 2026 10:15:07 PM).
MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.